Hospice benefits and phase I cancer trials

Annals of Internal Medicine

Volumn 138, Issue 4, 2003, Pages 335-337

  Byock, Ira ^a   Miles, Steven H ^b  

^a UNIVERSITY OF MONTANA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER; CANCER PATIENT; CANCER RESEARCH; CANCER SURVIVAL; CLINICAL RESEARCH; CLINICAL TRIAL; DRUG TOXICITY; FINANCIAL MANAGEMENT; HEALTH CARE POLICY; HEALTH INSURANCE; HOSPICE; HUMAN; MEDICAL ETHICS; MEDICARE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; REIMBURSEMENT; REVIEW; RISK BENEFIT ANALYSIS; TERMINAL CARE; TERMINALLY ILL PATIENT;

EID: 0037452495     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-138-4-200302180-00013     Document Type: Review

References (31)

1. Field MJ, Cassel CK, eds. Approaching Death: Improving Care at the End of Life. Washington, DC: Institute of Medicine; 1997.
2. A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT Principal Investigators. JAMA. 1995;274:1591-8. [PMID: 7474243]
3. Breitbart W, Rosenfeld BD, Passik SD, McDonald MV, Thaler H, Portenoy RK. The undertreatment of pain in ambulatory AIDS patients. Pain. 1996;65:243-9. [PMID: 8826513]
4. Bernabei R, Gambassi G, Lapane K, Landi F, Gatsonis C, Dunlop R, et al. Management of pain in elderly patients with cancer. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology. JAMA. 1998;279:1877-82. [PMID: 9634258]
5. Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, Stewart JA, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med. 1994;330:592-6. [PMID: 7508092]
6. Wolfe J, Grier HE, Klar N, Levin SB, Ellenbogen JM, Salem-Schatz S, et al. Symptoms and suffering at the end of life in children with cancer. N Engl J Med. 2000;342:326-33. [PMID: 10655532]
7. Byock I. Completing the continuum of cancer care: integrating life-prolongation and palliation. CA Cancer J Clin. 2000;50:123-32. [PMID: 10870488]
8. Lo B, Snyder L. Care at the end of life: guiding practice where there are no easy answers [Editorial]. Ann Intern Med. 1999;130:772-4. [PMID: 10357697]
9. Cancer care during the last phase of life. J Clin Oncol. 1998;16:1986-96. [PMID: 9586919]
10. Cassel CK, Foley KM. Principles for Care of Patients at the End of Life: An Emerging Consensus among the Specialties of Medicine. New York: Milbank Memorial Fund; 1999.
11. Statement on principles guiding care at the end of life. American College of Surgeons' Committee on Ethics. Bull Am Coll Surg. 1998;83:46. [PMID: 10179260]
12. American Academy of Pediatrics. Committee on Bioethics and Committee on Hospital Care. Palliative care for children. Pediatrics. 2000;106:351-7. [PMID: 10920167]
13. Foley KM, Gelband H, eds. Improving Palliative Care for Cancer. Washington, DC: National Acad Pr; 2001.
14. Mahoney JJ. The Medicare Hospice - 15 years of success. J Palliat Med. 1998;1:139-46.
15. Health Care Financing Administration. Hospice Manual. Baltimore, MD; Health Care Financing Administration: 1999. Accessed at www.hcfa.gov/pubforms/21_hospice/hs200.htm#_1_1 on 23 February 2002.
16. U.S. General Accounting Office. More Beneficiaries Use Hospice; Many Factors Contribute to Shorter Periods of Use. Washington, DC: U.S. General Accounting Office; 18 September 2000. Publication GAO/T-HEHS-00-201. Accessed at www.gao.gov/new.items/he00201t.pdf on 26 December 2002.
17. Hogan C, Lunney J, Gabel J, Lynn J. Medicare beneficiaries' costs of care in the last year of life. Health Aff (Millwood). 2001;20:188-95. [PMID: 11463076]
18. Janisch L, Mick R, Schilsky RL, Vogelzang NJ, O'Brien S, Kut M, et al. Prognostic factors for survival in patients treated in phase I clinical trials. Cancer. 1994;74:1965-73. [PMID: 8082103]
19. Oliverio R, Fraulo B. SUPPORT revisited: the nurse clinician's perspective. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. Holist Nurs Pract. 1998;13:1-7.
20. Daugherty CK, Ratain MJ, Siegler M. Pushing the envelope: informed consent in phase I trials [Editorial]. Ann Oncol. 1995;6:321-3. [PMID: 7619746]
21. Daugherty C, Ratain MJ, Grochowski E, Stocking C, Kodish E, Mick R, et al. Perceptions of cancer patients and their physicians involved in phase I trials. J Clin Oncol. 1995;13:1062-72. [PMID: 7738612]
22. Schaeffer MH, Krantz DS, Wichman A, Masur H, Reed E, Vinicky JK. The impact of disease severity on the informed consent process in clinical research. Am J Med. 1996;100:261-8. [PMID: 8629670]
23. Miller M. Phase I cancer trials. A collusion of misunderstanding. Hastings Cent Rep. 2000;30:34-43. [PMID: 10971892]
24. Kodish E, Stocking C, Ratain MJ, Kohrman A, Siegler M. Ethical issues in phase I oncology research: a comparison of investigators and institutional review board chairpersons. J Clin Oncol. 1992;10:1810-6. [PMID: 1403062]
25. Horng S, Emanuel EJ, Wilfond B, Rackoff J, Martz K, Grady C. Descriptions of benefits and risks in consent forms for phase I oncology trials. N Engl J Med. 2002;347:2134-40. [PMID: 12501226]
26. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Bethesda, MD: Office of Human Subjects Research, National Institutes of Health; 18 April 1979. Accessed at http://ohsr.od.nih.gov/mpa/belmont.php3 on 24 December 2002.
27. Criteria for Institutional Review Boards Approval of Research (2001) (45 CFR § 46.111).
28. National Archives and Records Administration's Office of the Federal Register and U.S. Government Printing Office. Memorandum on Increasing Participation of Medicare Beneficiaries in Clinical Trials. Weekly Compilation of Presidential Documents. 2000;36:1311-3.
29. Aaron HJ, Gelband H, eds. Extending Medicare Reimbursement in Clinical Trials. Washington, DC: National Acad Pr; 1999.
30. National Cancer Institute. Appendix VII: Informed Consent Checklist. In: Investigator's Handbook: A Manual for Participants in Clinical Trials of Investigational Agents. Version 4. Accessed at http://ctep.cancer.gov/handbook/append_7.html on 7 July 2002.
31. Myers F, Linder J, Beckett L, Enders S, Kishbaugh C, Gandara DR. Simultaneous care: a model to resolve conflict between investigational therapy and palliative care [Abstract]. Presented at the 38th Annual Meeting of American Society of Clinical Oncology, Orlando, FL; 21 May 2002. Abstract no. 1440.